TASS informs about this with reference to the FAS decision base.

"The Federal Antimonopoly Service has decided to agree on the maximum selling price declared for registration by the FBSI SSC VB Vector of Rospotrebnadzor (Russia) for the next drug ... Epivakkorona," the decision says.

It is noted that the agreed price limit in the amount of 4 thousand 210.10 rubles.

Earlier it was reported that the FAS agreed on the maximum selling price of the coronavirus vaccine from the Chumakov Center "KoviVac" in the amount of 4,330 rubles per package.